| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19:18 | Rosenblatt reiterates CoreWeave stock rating amid Meta cloud reports | ||
| 18:30 | TransMedics stock seen beating Q2 estimates on flight data, says William Blair | ||
| 17:42 | TD Cowen reiterates TransMedics stock Buy rating on transplant growth | ||
| 16:54 | B.Riley reiterates Buy on Oklo stock after DOE safety approval | ||
| 16:42 | UBS lowers X-Energy stock price target to $34 on higher costs | ||
| 16:42 | UBS cuts SLB stock price target to $66 on Iraq headwinds | ||
| 16:42 | UBS reiterates Constellation Brands stock rating on earnings beat | ||
| 16:42 | UBS reiterates Apple stock neutral on survey data, holds $296 target | ||
| 16:42 | UBS reiterates Buy on StandardAero stock citing MRO advantages | ||
| 16:42 | UBS reiterates Zebra Technologies stock rating citing competitive position | ||
| 16:42 | UBS raises Bloom Energy stock price target on expanded Brookfield deal | ||
| 16:42 | UBS raises United Rentals stock price target on construction rebound | ||
| 16:42 | UBS raises Oruka Therapeutics stock price target to $130 on efficacy data outlook | ||
| 16:18 | Craig-Hallum initiates Fractyl Health stock coverage with buy rating | ||
| 16:18 | Everpure stock price target maintained at $100 by TD Cowen | ||
| 16:18 | Constellation Brands stock price target maintained at $174 by TD Cowen | ||
| 16:18 | Protagonist Therapeutics stock rating reiterated at Buy by TD Cowen | ||
| 16:18 | TD Cowen lowers SLB stock price target to $62 on third-quarter outlook | ||
| 16:18 | Truist reiterates Five9 stock rating at Buy on leadership changes | ||
| 15:54 | Constellation Brands stock rating held at Outperform by Bernstein | ||
| 15:54 | Bernstein reiterates Air Products stock rating on project discipline | ||
| 15:54 | Truist reiterates Buy on Tyler Tech stock, keeps $440 target | ||
| 15:54 | Truist cuts EOG Resources stock price target on commodity prices | ||
| 15:54 | DA Davidson reiterates SPS Commerce stock rating after divestiture | ||
| 15:54 | BMO Capital maintains Amgen stock rating citing Tavneos concerns |